Latest News Continued


Dr. Bechert to present at the International Urban Wildlife Conference

Madison, WI, May 23, 2019. SpayVac for Wildlife Inc co-founder, Dr. Ursula Bechert, DVM, PhD, will be giving a talk on SpayVac use at the International Urban Wildlife Conference in Portland, OR.  Her presentation is scheduled for June 4, 2019.  Dr. Bechert has extensive experience participating in field trials and doing research on SpayVac in horses and elephants.

SpayVac for Wildlife Inc. Announces Agreement for Lab Space at University of Victoria Campus

Victoria, British Columbia and Madison ,WI , May 13, 2019 -- SpayVac for Wildlife Inc. (SFW) and the University of Victoria have announced an agreement permitting SFW to utilize lab space to manufacturer its vaccines.  

“By joining forces with the University of Victoria, SFW will be able to advance its agenda of obtaining regulatory approval in the US next year.  Not only have we conducted our first vaccine production at the university last week, we now have a place to develop assays to confirm the efficacy of each batch that we make in the future. These assays will play a critical role in our batch release process for all future doses of vaccine we manufacture,” said Mr. Mark Fraker, co-founder and Vice President of Operations for SFW. “We are grateful that the University of Victoria is willing to rent this space to us.” 

SFW will rent laboratory space in the Facility for Biomolecular Sample Preparation (FBS)​ - a Center for Advanced Materials and Related Technology at the University of Victoria.  Rebecca Hof, FBS Manager, says “We are very excited that the University is able to be a part of the advancement SFW’s vaccines for wildlife fertility control.”

About University of Victoria: The University of Victoria, is one of Canada's leading universities earning a reputation for commitment to research, scholarship and co-op education. 

About SpayVac for Wildlife Inc. (SFW) SFW Inc. was co-founded in 2017 by Dr. Ursula Bechert and Mr. Mark Fraker in order to focus on developing single-dose birth control for overabundant wildlife and feral species as a humane alternative to slaughter, poisoning, or relocation.  The company uses a patented, state-of-the-art nanoparticle technology platform to produce contraceptive vaccines.

SpayVac pZP vaccine has completed several multi-year trials in horses, deer, and seals where it consistently demonstrated long-term fertility control using a single dose.  In 2018, SFW Inc. acquired exclusive global rights to use DepoVax® and VacciMaxTM nanoparticle technology platforms specifically for contraceptive vaccines for wildlife from IMV Corporation of Halifax, Nova Scotia (OTCQX:IMMVD) (TSX:IMV)

SpayVac for Wildlife Inc. to Present at the Managing Free-roaming Equids and Sustainable Ecosystem conference in Reno, NV being held May 29-31, 2019

May 6, 2019,  Mr. Mark Fraker and Dr. Ursula Bechert will be presenting during the session on the Status of Free-roaming Equid Contraception Research during the Free-roaming Equids and Sustainable Ecosystem conference being held in Reno, NV May 29-31.  Dr. Bechert and Mr. Fraker will be presenting data that demonstrates the importance of injection site when using SpayVac in wild horses.

Mr. Fraker to present SpayVac data at the 37th Annual Native American Fish & Wildlife Society Annual Meeting on May 20, 2019

April 28, 2019 Mr. Mark Fraker will be speaking at the  Native American Fish & Wildlife Society being held in Arizona May 20-23, 2019.  He will speaking during the Free Ranging Equine Workshop being held on May 20, 2019.

SpayVac for Wildlife Inc completes manufacturing of conformance batches of vaccine

April 22, 2019.  SFW Inc has completed the manufacturing of its conformance batches of pZP vaccine.  A key part of its submission for EPA approval is the production And demonstration of consistent manufacturing methods.  With this important milestone successfully completed, the company has moved past one of the last steps before being able to submit to the EPA for US approval of its pZP vaccine.  SpayVac is the only contraceptive vaccine that has successful demonstrated long-lasting fertility control with a single dose.  

News Archives


Governor's Business Plan Competition Finalists Announced

April 2, 2019, Madison, WI: SpayVac for Wildlife Inc has advanced to Phase 3 for the 16th Annual Wisconsin Governor's Business Plan competition.  SpayVac for Wildlife will be attending the June 4-5 Wisconsin Entrepreneur's Conference in Milwaukee.  #WiTreps

SpayVac selected to present at Okanagan Angel Investor Forum

Feb . 8, 2019 Victoria, BC:  As a quarterfinalist, SFW Inc. will present the SpayVac story to potential investors at the OKGNTECH Angel Summit on Monday, February 10, 2019.   SFW Inc was selected to participate among a number of companies. OKGNTECH   Driving interest is the fact that the pZP vaccine for horses is close to submission and should come to market in the next year. 

PLC Endowment Trust Awards SpayVac-for-Wildlife $50,000 Grant

Oct. 16, 2018, Park City Utah. The Public Lands Council Endowment Trust selected SFW Inc. to receive funds intended to further our work on getting SpayVac pZP vaccine to market quickly.  PLC Endowment Trust specifically recognized that SpayVac has a potential role to play in protecting, enhancing, and preserving public lands.

First SpayVac batch manufactured

July 2, 2018.  Madison, WI and Victoria BC Canada.  The first production batch of SpayVac pZP vaccine has been produced.  It is currently going through validation and quality assurance testing.  No vaccine will be released until activity is confirmed.

New SpayVac publication

April 30, 2018.  "Twenty Years of SpayVac® Research: Potential Implications for Regulating Feral Horse and Burro Populations in the U.S." by Mark Fraker and Ursula Bechert was published in Human-Wildlife Interactions: Vol. 1: Iss. , Article 13.  You can link to the article:

Exclusive Global Licensing Agreement Announced

April 23, 2018. Madison, WI, USA; Victoria, BC, Canada; and Halifax, NS Canada

SpayVac-for-Wildlife, Inc., announced today an agreement with Immunovaccine, Inc. (TSX:IMV) (OTC:IMMVF) who granted them a license to two proprietary vaccine delivery platforms, VacciMax® and DepoVax™.  SpayVac-for-Wildlife, Inc. (SFW Inc.) will use these platforms to develop immunocontraceptive vaccines for use in populations of overabundant, feral and invasive mammals. SFW Inc.’s mission is to commercialize humane birth control tools for these over abundant populations.

SFW Inc. will produce and market SpayVac®, a pZP vaccine, using both of IMV’s proprietary VacciMax and DepoVax platforms. SFW Inc. will have global exclusive rights to use both of these platforms to develop humane, immunocontraceptive vaccines for control of overabundant, feral and invasive wildlife populations. 

For more go to our full announcement under Latest News in our Links pages